Unique ID issued by UMIN | UMIN000009718 |
---|---|
Receipt number | R000009464 |
Scientific Title | Evaluation of Safety and Efficacy about Resection of Pancreatic Cancer with Preoperatively Undetectable Intraabdominal Distant Metastasis |
Date of disclosure of the study information | 2013/01/08 |
Last modified on | 2014/02/07 09:52:09 |
Evaluation of Safety and Efficacy about Resection of Pancreatic Cancer with Preoperatively Undetectable Intraabdominal Distant Metastasis
Evaluation of Safety and Efficacy about Resection of Pancreatic Cancer with Preoperatively Undetectable Intraabdominal Distant Metastasis
Evaluation of Safety and Efficacy about Resection of Pancreatic Cancer with Preoperatively Undetectable Intraabdominal Distant Metastasis
Evaluation of Safety and Efficacy about Resection of Pancreatic Cancer with Preoperatively Undetectable Intraabdominal Distant Metastasis
Japan |
Pancreatic cancer
Hepato-biliary-pancreatic surgery |
Malignancy
NO
Safety about the resection of pancreatic cancer with intraabdominal distant metastasis
Safety
Perioperative safety
- Relapse free survival,
- Type of recurrence,
- Time course of tumor marker,
- The rate of administration of postoperarive adjuvant chemotherapy,
- Survival time after recurrence
- Over all survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Active
1
Treatment
Maneuver |
Resection of preoperatively undetectable intraabodominal distant metastasis and primary cancer, if R0 resection is possible.
20 | years-old | <= |
Not applicable |
Male and Female
(1) histolycally proven invasive pancreatic ductal adenocarcinoma
(2) no distant metastasis with preoperative imaging (CT, MRI, FDG-PET-CT)
(3) R0 resection is possible for primary cancer
(4) with tolerable health to operation
(5) no prior therapy for pancreas cancer
(6) not enrolled in other study with primary endpoint of resection or survival
(7) no other active cancer
(8) with consent in a writing form
(9) 20 years old or older
(10) with judgement
(1) not diagnosed as invasive pancreatic ductal adenocarcinoma
(2) with distant metastasis
(3) R2 resection is expected
(4) without tlerable health to operation
(5) recurrent pancreatic cancer
(6) enrolled in other study with primary endpoint of resection or survival
(7) with another active cancer
(8) in pregnancy
(9) younger than 20 years old
(10) without judgement
15
1st name | |
Middle name | |
Last name | Hiroki Hayashi |
Tohoku University Hospital
Hepato-Biliary Pancreatic surgery
Sendai
022-717-7205
hiroki@surg1.med.tohoku.ac.jp
1st name | |
Middle name | |
Last name | Hiroki Hayashi |
Tohoku University Hospital
Hepato-Biliary Pancreatic surgery
1-1 Seiryo-machi, Aoba-ku, Sendai
022-717-7205
hiroki@surg1.med.tohoku.ac.jp
Hepato-Biliary Pancreatic surgery, Tohoku University Hospital
none
Self funding
NO
東北大学病院(宮城県)
2013 | Year | 01 | Month | 08 | Day |
Unpublished
Enrolling by invitation
2012 | Year | 12 | Month | 22 | Day |
2013 | Year | 01 | Month | 09 | Day |
2018 | Year | 01 | Month | 08 | Day |
2018 | Year | 01 | Month | 08 | Day |
2018 | Year | 01 | Month | 08 | Day |
2018 | Year | 01 | Month | 08 | Day |
2013 | Year | 01 | Month | 07 | Day |
2014 | Year | 02 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009464